Antidepressant reduced Covid-19 hospitalisation risk, says study

Antidepressant reduced Covid-19 hospitalisation risk, says study - Hello loyal readers FeedGoogle, In the article you are reading this time with the title Antidepressant reduced Covid-19 hospitalisation risk, says study, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

According to a study, treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third. — Reuters pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. PARIS, Oct 27 ― Treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study showed today.Authors said the research could help boost low-cost protection against severe sickness or death in countries that have yet to receive adequate vaccine doses during a grossly uneven rollout.Fluvoxamine is traditionally used to treat mental health conditions such as depression and obsessive-compulsive disorders and was selected for trial due to its anti-inflammatory properties.Many problems stemming from Covid are caused by swelling as the…